文献速递慢性肾脏病遗传性与小管间质肾病

尿DKK3可揭示COPD患者中沉默的进行性肾损伤

Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease.
PubMed 文献 · Kidney Int · 2021-07-06

在COSYCONET前瞻性多中心队列2314例稳定期COPD患者中,基线尿DKK3(而非蛋白尿或eGFR)可识别随访37.1个月内eGFR下降超过10%和超过20%风险显著升高的患者。在eGFR超过90 ml/min/1.73m2且蛋白尿低于30 mg/g的患者中,DKK3同样与eGFR下降风险显著相关,并与COPD标志物FEV1下降相关。小鼠实验显示敲除Dkk3可减轻烟雾联合CKD模型中的肺部炎症并保护肾功能。

要点

  • 基线尿DKK3可识别COPD患者中eGFR下降超过10%或20%的高风险者。
  • 在eGFR超过90且蛋白尿低于30 mg/g的患者中,DKK3仍与eGFR下降相关。
  • 尿DKK3或可作为早期识别沉默进行性CKD的候选标志物。

核心结论

  • 尿DKK3可能是早期识别沉默进行性CKD及COPD不良结局的候选标志物。

研究设计与样本

  • COSYCONET为前瞻性多中心试验,纳入2314例稳定期COPD患者,随访37.1个月。
  • 另在野生型和Dkk3-/-小鼠中采用香烟烟雾诱导肺损伤联合CKD模型进行实验。

主要发现

  • 基线尿DKK3与随访期间eGFR下降超过10%风险相关,OR为1.54(95%CI 1.13-2.08)。
  • 基线尿DKK3与eGFR下降超过20%风险相关,OR为2.59(95%CI 1.28-5.25)。
  • 在eGFR超过90 ml/min/1.73m2且蛋白尿低于30 mg/g的患者中,DKK3与eGFR下降风险显著相关。
  • DKK3与COPD标志物FEV1下降相关,OR为2.90(95%CI 1.70-4.68)。
  • 小鼠模型中遗传敲除Dkk3可减轻肺部炎症并保护肾功能。

临床怎么用

  • 在COPD患者中可考虑检测尿DKK3以辅助识别eGFR尚正常且蛋白尿阴性的进行性肾损伤高风险者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic kidney disease (CKD) represents a global public health problem with high disease related morbidity and mortality. Since CKD etiology is heterogeneous, early recognition of patients at risk for progressive kidney injury is important. Here, we evaluated the tubular epithelial derived glycoprotein dickkopf-3 (DKK3) as a urinary marker for the identification of progressive kidney injury in a non-CKD cohort of patients with chronic obstructive pulmonary disease (COPD) and in an experimental model. In COSYCONET, a prospective multicenter trial comprising 2,314 patients with stable COPD (follow-up 37.1 months), baseline urinary DKK3, proteinuria and estimated glomerular filtration rate (eGFR) were tested for their association with the risk of declining eGFR and the COPD marker, forced expiratory volume in one second. Baseline urinary DKK3 but not proteinuria or eGFR identified patients with a significantly higher risk for over a 10% (odds ratio: 1.54, 95% confidence interval: 1.13-2.08) and over a 20% (2.59: 1.28-5.25) decline of eGFR during follow-up. In particular, DKK3 was associated with a significantly higher risk for declining eGFR in patients with eGFR over 90 ml/min/1.73m2 and proteinuria under 30 mg/g. DKK3 was also associated with declining COPD marker (2.90: 1.70-4.68). The impact of DKK3 was further explored in wild-type and Dkk3-/- mice subjected to cigarette smoke-induced lung injury combined with a CKD model. In this model, genetic abrogation of DKK3 resulted in reduced pulmonary inflammation and preserved kidney function. Thus, our data highlight urinary DKK3 as a possible marker for early identification of patients with silent progressive CKD and for adverse outcomes in patients with COPD.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Schunk SJ, Beisswenger C, Ritzmann F, et al. Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease. Kidney Int. 2021. PMID: 34237325. doi:10.1016/j.kint.2021.06.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。